The Knight Diagnostic Laboratories participates in Clinical Cytogenetics, Clinical Molecular Genetics and Molecular Genetic Pathology training programs with the OHSU Department of Molecular and Medical Genetics and the OHSU Department of Pathology.   Fellows learn both technical and interpretive aspects of current testing as well as participating in bringing new tests and platforms into clinical use.  

For more information and application guidelines, please visit:   

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More